Longevity announced that it has elected to extend the date for completing a business combination from Nov. 30 to May 29. The SPAC has a proposed business combination with 4D pharma announced in October. The extension gives the parties time to fulfill the remaining conditions to the merger, including 4D’s filing of a registration statement to apply for its American Depositary Shares to trade on the Nasdaq. Read more.
Related Posts
Edoc Acquisition Shareholders Approve Australian Oilseeds Deal
The transaction had a post-combination valuation of $190 million when announced in December 2022.
Altimar II Prices $300M IPO
The new SPAC has not identified a target sector, but in its initial SEC filing said, “we intend to focus on two characteristics as a common theme: a strong organic growth plan coupled with a compelling business model that is materially cash generative at maturity.”
Fortress Value III and IV Liquidating Early to Dodge Excise Tax on Redemptions
With both SPACs, Fortress management cited an inability to reach an agreement with potential merger partners on valuation, among other factors.
Riverview Acquisition Stockholders Approve Westrock Coffee Merger
Riverview disclosed earlier this week that 73.5% of its outstanding Class A shares were redeemed ahead of the vote. However, the SPAC's remaining $66 million cash in trust and PIPE funding more than covers the $250 million minimum cash condition, getting the deal across the finish line.